NFKB1 and viral load: Many of the anti-inflammatory drugs, including sodium salicylate and dexamethasone, commonly used for symptomatic management of viral diseases, suppress NF-κB signaling (Chamkouri et al., 2023; Di Bella et al., 2022; Yu et al., 2020).